• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体系统和 C1q 在慢性丙型肝炎病毒感染和混合性冷球蛋白血症中的作用。

The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.

机构信息

Division of Liver Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Department of Pharmaceutical and Biological Sciences, California Northstate University, Elk Grove, CA, United States.

出版信息

Front Immunol. 2018 May 29;9:1001. doi: 10.3389/fimmu.2018.01001. eCollection 2018.

DOI:10.3389/fimmu.2018.01001
PMID:29910796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5992393/
Abstract

The complement system bridges innate and adaptive immunity against microbial infections, with viral infection being a major trigger. Activation of the classical, alternative, and lectin pathways have been reported in chronic hepatitis C virus (HCV) infection and/or cryoglobulinemia. HCV infection leads to dysregulation of complement-mediated immune responses. Clinical and experimental evidence support involvement of complement in intra- and extrahepatic manifestations of HCV infection, such as liver fibrosis and type II cryoglobulinemia. In this review, we summarize studies that have investigated the interplay between HCV and the complement system to establish chronic infection and autoimmunity, as well as the association between HCV pathogenesis and abnormal complement profiles. Several unanswered questions are highlighted which suggest additional informative lines of investigation.

摘要

补体系统在针对微生物感染的先天免疫和适应性免疫中发挥着桥梁作用,而病毒感染是主要的触发因素。慢性丙型肝炎病毒 (HCV) 感染和/或冷球蛋白血症中已报道了经典、替代和凝集素途径的激活。HCV 感染导致补体介导的免疫反应失调。临床和实验证据支持补体参与 HCV 感染的肝内和肝外表现,如肝纤维化和 II 型冷球蛋白血症。在这篇综述中,我们总结了研究 HCV 与补体系统之间相互作用以建立慢性感染和自身免疫的研究,以及 HCV 发病机制与异常补体谱之间的关联。强调了几个尚未解决的问题,这些问题表明需要进行更多有启发性的研究。

相似文献

1
The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.补体系统和 C1q 在慢性丙型肝炎病毒感染和混合性冷球蛋白血症中的作用。
Front Immunol. 2018 May 29;9:1001. doi: 10.3389/fimmu.2018.01001. eCollection 2018.
2
Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.丙型肝炎病毒IV型慢性感染中的抗C1q:与自身免疫性风湿表现的关联
Immunol Invest. 2015;44(1):45-55. doi: 10.3109/08820139.2014.932378. Epub 2014 Jul 16.
3
Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage.C1q蛋白球状结构域受体在丙型肝炎病毒相关冷球蛋白血症性血管损伤发病机制中的作用
J Immunol. 2009 Nov 1;183(9):6013-20. doi: 10.4049/jimmunol.0902038. Epub 2009 Oct 14.
4
Anti-C1q antibodies in hepatitis C virus infection.丙型肝炎病毒感染中的抗C1q抗体。
Clin Exp Immunol. 2006 Aug;145(2):308-12. doi: 10.1111/j.1365-2249.2006.03153.x.
5
Rheumatoid factor, complement, and mixed cryoglobulinemia.类风湿因子、补体与混合性冷球蛋白血症。
Clin Dev Immunol. 2012;2012:439018. doi: 10.1155/2012/439018. Epub 2012 Aug 26.
6
Renal Manifestations of Hepatitis C Virus.丙型肝炎病毒的肾脏表现。
Clin Liver Dis. 2017 Aug;21(3):487-497. doi: 10.1016/j.cld.2017.03.005. Epub 2017 Apr 27.
7
[The extrahepatic site of hepatitis C virus: clinical manifestations and prognostic value].[丙型肝炎病毒的肝外部位:临床表现及预后价值]
Ter Arkh. 2009;81(11):63-8.
8
Hepatitis C Virus-Associated Extrahepatic Manifestations in Lung and Heart and Antiviral Therapy-Related Cardiopulmonary Toxicity.丙型肝炎病毒相关的肺和心脏肝外表现及抗病毒治疗相关的心肺毒性
Viral Immunol. 2017 Nov;30(9):633-641. doi: 10.1089/vim.2017.0009. Epub 2017 Sep 27.
9
Mixed cryoglobulinemia in hepatitis C patients. GERMIVIC.丙型肝炎患者的混合性冷球蛋白血症。GERMIVIC。
Ann Med Interne (Paris). 2000 Feb;151(1):20-9.
10
[Autoimmune and rheumatic aspects of HCV infection (lecture)].[丙型肝炎病毒感染的自身免疫与风湿方面(讲座)]
Klin Med (Mosk). 1999;77(12):14-8.

引用本文的文献

1
Normocomplementemic Urticarial Vasculitis Following Influenza Vaccination: A Case Report and Review of the Literature.流感疫苗接种后补体正常的荨麻疹性血管炎:一例报告及文献复习
Int Med Case Rep J. 2024 Sep 28;17:823-829. doi: 10.2147/IMCRJ.S483023. eCollection 2024.
2
Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals.慢性丙型肝炎病毒感染、肝外疾病及新型直接抗病毒药物的影响
Pathogens. 2024 Apr 19;13(4):339. doi: 10.3390/pathogens13040339.
3
Macrophages regulate gastrointestinal motility through complement component 1q.巨噬细胞通过补体成分 1q 调节胃肠道蠕动。
Elife. 2023 Apr 26;12:e78558. doi: 10.7554/eLife.78558.
4
Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus.血清胱抑素C是丙型肝炎病毒患者早期肾功能障碍的生物标志物。
Egypt Liver J. 2022;12(1):67. doi: 10.1186/s43066-022-00231-x. Epub 2022 Nov 24.
5
Immunologic markers, vasculitis-associated autoantibodies, and complement levels in patients with COVID-19.新型冠状病毒肺炎患者的免疫标志物、血管炎相关自身抗体及补体水平
J Res Med Sci. 2021 Oct 18;26:103. doi: 10.4103/jrms.JRMS_923_20. eCollection 2021.
6
Patients with Covid 19 have significantly reduced CH50 activity.新冠肺炎患者的总补体活性显著降低。
Virusdisease. 2021 Dec;32(4):681-689. doi: 10.1007/s13337-021-00710-6. Epub 2021 Oct 2.
7
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins.冷球蛋白:神秘蛋白的鉴定、分类和新型生物标志物。
Adv Clin Chem. 2021;104:299-340. doi: 10.1016/bs.acc.2020.09.006. Epub 2020 Oct 31.
8
In the Crosshairs: RNA Viruses OR Complement?在瞄准镜中:RNA 病毒还是补体?
Front Immunol. 2020 Sep 29;11:573583. doi: 10.3389/fimmu.2020.573583. eCollection 2020.
9
Urticarial vasculitis in a COVID-19 recovered patient.一名新冠康复患者的荨麻疹性血管炎
Int J Dermatol. 2020 Oct;59(10):1285-1286. doi: 10.1111/ijd.15112. Epub 2020 Aug 9.
10
The complement system in liver diseases: Evidence-based approach and therapeutic options.肝脏疾病中的补体系统:循证方法与治疗选择
J Transl Autoimmun. 2019 Sep 18;2:100017. doi: 10.1016/j.jtauto.2019.100017. eCollection 2019 Dec.

本文引用的文献

1
Newly discovered hepatitis C virus minicores circulate in human blood.新发现的丙型肝炎病毒微型核心在人体血液中循环。
Hepatol Commun. 2017 Nov 12;2(1):21-28. doi: 10.1002/hep4.1125. eCollection 2018 Jan.
2
Complement Evasion Strategies of Viruses: An Overview.病毒的补体逃避策略:概述
Front Microbiol. 2017 Jun 16;8:1117. doi: 10.3389/fmicb.2017.01117. eCollection 2017.
3
C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions.C1复合物:一种用于补体和非补体功能的适应性蛋白水解模块。
Front Immunol. 2017 May 24;8:592. doi: 10.3389/fimmu.2017.00592. eCollection 2017.
4
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience.直接作用抗病毒药物治疗丙型肝炎病毒相关混合性冷球蛋白血症:单中心经验
Arthritis Res Ther. 2017 Apr 8;19(1):74. doi: 10.1186/s13075-017-1280-6.
5
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.丙型肝炎病毒感染的口服直接作用抗病毒药物治疗:一项系统评价
Ann Intern Med. 2017 May 2;166(9):637-648. doi: 10.7326/M16-2575. Epub 2017 Mar 21.
6
Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.直接作用抗病毒药物治疗混合性冷球蛋白血症的疗效和安全性。
Am J Gastroenterol. 2017 Aug;112(8):1298-1308. doi: 10.1038/ajg.2017.49. Epub 2017 Mar 14.
7
Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.索磷布韦联合达卡他韦治疗丙型肝炎病毒相关冷球蛋白血症血管炎的疗效和安全性。
Gastroenterology. 2017 Jul;153(1):49-52.e5. doi: 10.1053/j.gastro.2017.03.006. Epub 2017 Mar 10.
8
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.直接作用抗病毒疗法恢复丙型肝炎病毒相关冷球蛋白血症血管炎患者的免疫耐受。
Gastroenterology. 2017 Jun;152(8):2052-2062.e2. doi: 10.1053/j.gastro.2017.02.037. Epub 2017 Mar 6.
9
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response.丙型慢性肝炎患者持续的肝脏炎症与持续病毒学应答
PLoS One. 2017 Feb 14;12(2):e0171755. doi: 10.1371/journal.pone.0171755. eCollection 2017.
10
Hepatitis C Virus: A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy.丙型肝炎病毒:治疗指南、成本效益及治疗可及性综述
J Clin Transl Hepatol. 2016 Dec 28;4(4):310-319. doi: 10.14218/JCTH.2016.00027. Epub 2016 Nov 3.